Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo Nordisk blockbusters Wegovy and Ozempic, are slated for price talks.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes to improve access to care.

U.S. division has sued CMS over the Medicare drug pricing negotiations policy included in the Inflation Reduction Act. In its lawsuit filed in D.C. federal court, the Israel-based drugmaker says that guidance CMS has issued on price negotiations "gives the agency even more unchecked price-setting power

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage through the Health Insurance Marketplace for the 2025 enrollment period that ended Jan.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. T

Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.

"If CMS reduces it below 90%, I will be the first to push to eliminate, as that was not the deal we made," said Rep. Donny Lambeth of Forsyth County.

I'm one of many people, I'm sure, who've been blindsided by IRMAA. I'm trying to plan my 2025 income now to minimize my 2027 Medicare charges. I'm filing single. It seems that no one knows what the thresholds are yet for 2027. Is that true? If so, can we estimate?